the incidence of fatal and nonfatal thromboemboli and bleeding episodes was compared in 53 patients who received sodium warfarin and in 17 successive patients who received no sodium warfarin after beall mitral valve replacement .
C0040038
thromboemboli
C0376218
sodium warfarin